Holdings of Direxion Daily S&P Biotech Bull 3X Shares
Direxion Shares ETF Trust · 145 declared positions · as of Apr 30, 2026
Original filing · Net assets 518.9M $ · Ten largest lines: 14.8 % of the equity sleeve
Sector breakdown
- Health care 11.8 %
- Materials 1.1 %
- Industrials 1.1 %
- Unattributed 85.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 95.2 %
- IE 1.5 %
- CH 1.2 %
- BM 1.1 %
- VG 0.5 %
- NL 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 139 | 406.1M $ | 95.23 % |
| 2 | IE | 2 | 6.5M $ | 1.53 % |
| 3 | CH | 1 | 5.1M $ | 1.19 % |
| 4 | BM | 1 | 4.7M $ | 1.10 % |
| 5 | VG | 1 | 2.1M $ | 0.50 % |
| 6 | NL | 1 | 1.9M $ | 0.45 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Precigen Inc | 343,575 | 1.4M $ | 0.28 % |
| 102 | SELLAS Life Sciences Group Inc | 268,465 | 1.3M $ | 0.26 % |
| 103 | Tyra Biosciences Inc | 37,514 | 1.3M $ | 0.25 % |
| 104 | Absci Corp | 259,355 | 1.3M $ | 0.25 % |
| 105 | Annexon Inc | 218,784 | 1.3M $ | 0.25 % |
| 106 | Kura Oncology Inc | 144,395 | 1.3M $ | 0.25 % |
| 107 | Sana Biotechnology Inc | 380,569 | 1.3M $ | 0.24 % |
| 108 | ArriVent Biopharma Inc | 40,097 | 1.2M $ | 0.24 % |
| 109 | ORIC Pharmaceuticals Inc | 124,292 | 1.2M $ | 0.24 % |
| 110 | Rigel Pharmaceuticals Inc | 40,551 | 1.2M $ | 0.23 % |
| 111 | Janux Therapeutics Inc | 81,512 | 1.2M $ | 0.23 % |
| 112 | CytomX Therapeutics Inc | 258,130 | 1.1M $ | 0.21 % |
| 113 | Savara Inc | 203,377 | 1.1M $ | 0.21 % |
| 114 | ARS Pharmaceuticals Inc | 126,616 | 1M $ | 0.20 % |
| 115 | ZENAS BIOPHARMA INC | 51,847 | 1M $ | 0.19 % |
| 116 | Cullinan Therapeutics Inc | 74,789 | 976K $ | 0.19 % |
| 117 | Xencor Inc | 81,350 | 970.5K $ | 0.19 % |
| 118 | Ironwood Pharmaceuticals Inc | 233,156 | 961.8K $ | 0.19 % |
| 119 | Sionna Therapeutics Inc | 23,827 | 922.1K $ | 0.18 % |
| 120 | Bicara Therapeutics Inc | 40,903 | 882.7K $ | 0.17 % |
| 121 | HYPERLIQUID STRATEGIES INC | 142,920 | 860.4K $ | 0.17 % |
| 122 | Prime Medicine Inc | 232,034 | 822.6K $ | 0.16 % |
| 123 | Vor BioPharma Inc | 54,358 | 779K $ | 0.15 % |
| 124 | Emergent BioSolutions Inc | 91,705 | 754.7K $ | 0.15 % |
| 125 | REGENXBIO Inc | 79,519 | 713.3K $ | 0.14 % |
| 126 | Vanda Pharmaceuticals Inc | 99,351 | 705.4K $ | 0.14 % |
| 127 | First Tracks Biotherapeutics Inc | 29,328 | 682.5K $ | 0.13 % |
| 128 | 4D Molecular Therapeutics Inc | 76,847 | 681.6K $ | 0.13 % |
| 129 | Allogene Therapeutics Inc | 303,899 | 647.3K $ | 0.12 % |
| 130 | Altimmune Inc | 248,923 | 647.2K $ | 0.12 % |
| 131 | Verastem Inc | 117,456 | 641.3K $ | 0.12 % |
| 132 | Prothena Corp PLC | 57,328 | 634K $ | 0.12 % |
| 133 | Lexeo Therapeutics Inc | 108,595 | 618.4K $ | 0.12 % |
| 134 | Myriad Genetics Inc | 125,944 | 598.2K $ | 0.12 % |
| 135 | Arbutus Biopharma Corp | 132,235 | 555.4K $ | 0.11 % |
| 136 | Rocket Pharmaceuticals Inc | 151,991 | 528.9K $ | 0.10 % |
| 137 | Ocugen Inc | 304,496 | 526.8K $ | 0.10 % |
| 138 | Anavex Life Sciences Corp | 154,727 | 516.8K $ | 0.10 % |
| 139 | Akebia Therapeutics Inc | 352,079 | 485.9K $ | 0.09 % |
| 140 | Invivyd Inc | 329,668 | 461.5K $ | 0.09 % |
| 141 | MiMedx Group Inc | 133,086 | 447.2K $ | 0.09 % |
| 142 | Perspective Therapeutics Inc | 99,897 | 389.6K $ | 0.08 % |
| 143 | Compass Therapeutics Inc | 210,822 | 373.2K $ | 0.07 % |
| 144 | Replimune Group Inc | 127,521 | 327.7K $ | 0.06 % |
| 145 | DAMORA THERAPEUTICS INC | 5,472 | 140.4K $ | 0.03 % |